Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26Hiroyuki Gatanaga, Shinichi Oka, Taishi Kuwahara et al.|Clinical Infectious Diseases|2007Cited by 222
Selection of escape mutant by HLA‐C‐restricted HIV‐1 Pol‐specific cytotoxic T lymphocytes carrying strong ability to suppress HIV‐1 replicationKazutaka Honda, Masafumi Takiguchi, Nan Zheng et al.|European Journal of Immunology|2010Cited by 28